Literature DB >> 12379897

Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.

D R Couriel1, G Z Beguelin, S Giralt, M De Lima, C Hosing, M A Kharfan-Dabaja, A Anagnostopoulos, R Champlin.   

Abstract

Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic stem cell transplantation. Polymyositis can occur in association with chronic GVHD and mimics the idiopathic form of the disease. We report two cases of chronic GVHD-associated polymyositis and review the published literature. The two patients presented 13 and 19 months after allogeneic transplantation with characteristic features of muscular hypotrophy, proximal muscle weakness, pain, elevated creatine phosphokinase (CPK), aldolase and SGPT. Interestingly, both patients had HLA DR52 genes, which is frequently reported in association with idiopathic polymyositis. Electromyogram (EMG) and muscle biopsy confirmed the diagnosis. Treatment with cyclosporine or tacrolimus resulted in complete and sustained remission of polymyositis in both cases. A review of the literature shows cyclosporine and steroids are well-described treatment options for patients with myositis in post transplant, as well as idiopathic cases. The duration of immunosuppressive treatment has varied in different reports, and there is a risk of recurrence when immunosuppression is tapered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379897     DOI: 10.1038/sj.bmt.1703711

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  18 in total

1.  Neuromuscular complications after hematopoietic stem cell transplantation.

Authors:  Susanne Koeppen; Abhiyrahmi Thirugnanasambanthan; Michael Koldehoff
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

2.  Generalized intramuscular granulocytic sarcoma mimicking polymyositis.

Authors:  Jan Fritz; Wichard Vogel; Claus D Claussen; Martin Wehrmann; Philippe L Pereira; Marius S Horger
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

3.  Chronic graft-versus-host disease mimicking rapid progressive rheumatoid arthritis with atlantoaxial subluxation.

Authors:  Hui-Ting Lee; Wei-Sheng Chen; Chung-Tei Chou; Ming-Han Chen; Chang-Youh Tsai
Journal:  BMJ Case Rep       Date:  2009-09-02

4.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Hematol Oncol Stem Cell Ther       Date:  2012

5.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Bone Marrow Transplant       Date:  2012-03       Impact factor: 5.483

6.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Paul A Carpenter; Carrie L Kitko; Sharon Elad; Mary E D Flowers; Juan C Gea-Banacloche; Jörg P Halter; Flora Hoodin; Laura Johnston; Anita Lawitschka; George B McDonald; Anthony W Opipari; Bipin N Savani; Kirk R Schultz; Sean R Smith; Karen L Syrjala; Nathaniel Treister; Georgia B Vogelsang; Kirsten M Williams; Steven Z Pavletic; Paul J Martin; Stephanie J Lee; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

Review 7.  A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.

Authors:  Fotios V Michelis; Vera Bril; Jeffrey H Lipton
Journal:  Int J Hematol       Date:  2015-03-03       Impact factor: 2.490

8.  IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD.

Authors:  Manish J Butte; Charles Haines; Francisco A Bonilla; Jennifer Puck
Journal:  Clin Immunol       Date:  2007-09-12       Impact factor: 3.969

9.  Polymyositis after donor lymphocyte infusion.

Authors:  Juan Montoro; Juan Carlos Hernández-Boluda; Cristina Arbona; Carlos Solano
Journal:  Int J Hematol       Date:  2012-08-19       Impact factor: 2.490

Review 10.  Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.

Authors:  Shiro Matsubara; Koichi Kondo; Keizo Sugaya; Kazuhito Miyamoto
Journal:  Clin Rheumatol       Date:  2012-08-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.